Skip Navigation


Alcohol and Alcoholism Advance Access originally published online on October 5, 2004
Alcohol and Alcoholism 2004 39(6):486-492; doi:10.1093/alcalc/agh098
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
39/6/486    most recent
agh098v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by LALLEMAND, F.
Right arrow Articles by DE WITTE, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LALLEMAND, F.
Right arrow Articles by DE WITTE, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Alcohol & Alcoholism Vol. 39, No. 6 © Medical Council on Alcohol 2004; all rights reserved

EFFECTS OF CB1 CANNABINOID RECEPTOR BLOCKADE ON ETHANOL PREFERENCE AFTER CHRONIC ALCOHOL ADMINISTRATION COMBINED WITH REPEATED RE-EXPOSURES AND WITHDRAWALS

FRÉDÉRIC LALLEMAND1, PHILIPPE SOUBRIÉ2 and PHILIPPE DE WITTE1,*

1 Laboratoire de Biologie du Comportement, Université Catholique de Louvain, Louvain-la-Neuve, Belgium and 2 Sanofi-Synthélabo Recherche, Montpellier, France

* Author to whom correspondence should be addressed at: Biologie du Comportement, Université Catholique de Louvain, 1 Croix du Sud, 1348 Louvain-la-Neuve, Belgium. Tel.: +32 10 474384; Fax: +32 10 474094; E-mail: dewitte{at}bani.ucl.ac.be

(Received 27 March 2004; first review notified 11 May 2004; in revised form 1 July 2004; accepted 3 July 2004)

Aims: The cannabinoid CB1 receptor antagonist, SR141716A, differentially affects the ethanol preference of chronically alcoholized rats when administered during cycles of ethanol exposure and withdrawal. In this study, ethanol preference was investigated in chronically alcoholized rats that underwent regular withdrawal periods during which the brain cannabinoid CB1 receptor antagonist, SR141716A, was administered. Methods: The cannabinoid receptor antagonist SR141716A, 3 or 10 mg/kg/day, was administered i.p. to Wistar rats at the conclusion of a 4-week period of chronic alcoholization, as they commenced a cycle of alcohol withdrawal for 10 days followed by a period of 10 days chronic ethanol exposure. In a second set of experiments, an additional cycle of ethanol withdrawal and re-exposure was given. Preference for ethanol versus water started at the end of the first or second chronic ethanol re-exposure for a period of at least 30 days. Results: In rats pretreated with the higher dose of SR141716A, ethanol preference during free choice was significantly increased after two ethanol re-exposures. In contrast, pretreatment with the lower SR141716A dose induced no significant change in ethanol intake during the free choice followed by either one or two ethanol re-exposures. Conclusions: SR141716A, 10 mg/kg/day dose, induced a significant increase in ethanol preference which was dependent on both the number of ethanol withdrawals and chronic ethanol re-exposures, while 3 mg/kg/day had no significant effect on ethanol preference.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.